학술논문

Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Document Type
Journal
Source
ALLERGY; DEC 3 2022, 11p.
Subject
Language
English
ISSN
13989995